Infection after acute stroke is associated with poor short-term outcome

Acta Neurologica Scandinavica

Volumn 115, Issue 5, 2007, Pages 331-338

  Kwan, J ^a   Hand, P ^b  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Cerebrovascular; Hospital; Infection; Outcome; Recovery; Stroke

Indexed keywords

AGED; ARTICLE; DECUBITUS; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; RISK FACTOR; SEIZURE; STROKE; TRANSIENT ISCHEMIC ATTACK; URINE CATHETER;

ACUTE DISEASE; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; FEMALE; HOSPITAL MORTALITY; HUMANS; INFECTION; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PATIENT DISCHARGE; PRESSURE ULCER; RISK FACTORS; SEVERITY OF ILLNESS INDEX; URINARY CATHETERIZATION;

EID: 34247849272     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00783.x     Document Type: Article

References (52)

1. Chamorro A, Horcajada JP, Obach V et al. The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke 2005 36 : 1495 500.
2. Dromerick A, Reding MJ. Medical and neurological complications during inpatient stroke rehabilitation. Stroke 1994 25 : 358 61.
3. Langhorne P, Stott DJ, Robertson L et al. Medical complications after stroke: a multicenter study. Stroke 2000 31 : 1223 9.
4. Vargas M, Horcajada JP, Obach V et al. Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke 2006 37 : 461 5.
5. Davenport RJ, Dennis M, Wellwood I, Warlow C. Complications after acute stroke. Stroke 1996 27 : 415 20.
6. Georgilis K, Plomaritoglou A, Dafni U, Bassiakos Y, Vemmos K. Aetiology of fever in patients with acute stroke. J Intern Med 1999 246 : 203 9.
7. Johnston KC, Li JY, Lyden PD et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. Stroke 1998 29 : 447 53.
8. Greenberg JH. Glucose and oxygen metabolism in ischaemia. In : Ginsberg MD, Bogousslavsky J, eds. Cerebrovascular disease. Pathophysiology, diagnosis, and management. Malden : Blackwell Science, 1998 227 48.
9. Busto R, Ginsberg MD. The influence of altered brain temperature in cerebral ischaemia. In : Ginsberg MD, Bogousslavsky J, eds. Cerebrovascular disease. Pathophysiology, diagnosis, and management. Malden : Blackwell Science, 1998 287 307.
10. Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ. Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke 2004 35 : 1421 5.
11. Ashare A, Powers LS, Butler NS, Doerschug KC, Monick MM, Hunninghake GW. Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am J Physiol Lung Cell Mol Physiol 2005 288 : L633 40.
12. Kwan J, Hand P. Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. Q J Med 2006 99 : 625 33.
13. Birschel P, Ellul J, Barer D. Progressing stroke: towards an internationally agreed definition. Cerebrovasc Dis 2004 17 : 242 52.
14. Henon H, Godefroy O, Leys D et al. Early predictors of death and disability after acute cerebral ischemic event. Stroke 1995 26 : 392 8.
15. Viitanen M, Winblad B, Asplund K. Autopsy-verified causes of death after stroke. Acta Med Scand 1987 222 : 401 8.
16. Vernino S, Brown RD Jr., Sejvar JJ, Sicks JD, Petty GW, O'Fallon WM. Cause-specific mortality after first cerebral infarction: a population-based study. Stroke 2003 34 : 1828 32.
17. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke 1988 19 : 1497 500.
18. Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet 1975 7905 : 480 4.
19. Multicenter trial of hemodilution in ischemic stroke-background and study protocol. Scandinavian Stroke Study Group. Stroke 1985 16 : 885 90.
20. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991 337 : 1521 6.
21. Evans A, Perez I, Harraf F et al. Can differences in management processes explain different outcomes between stroke unit and stroke-team care? Lancet 2002 358 : 1586 92.
22. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol 2004 11 : 49 53.
23. Grau AJ, Buggle F, Schnitzler P, Spiel M, Lichy C, Hacke W. Fever and infection early after ischemic stroke. J Neurol Sci 1999 171 : 115 20.
24. Kalra L, Yu G, Wilson K, Roots P. Medical complications during stroke rehabilitation. Stroke 1995 26 : 990 4.
25. Roth EJ, Lovell L, Harvey RL, Heinemann AW, Semik P, Diaz S. Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke 2001 32 : 523 9.
26. Dromerick AW, Edwards DF. Relation of postvoid residual to urinary tract infection during stroke rehabilitation. Arch Phys Med Rehabil 2003 84 : 1369 72.
27. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005 6 : 775 86.
28. Woiciechowsky C, Schoning B, Lanksch WR, Volk HD, Docke WD. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med 1999 77 : 769 80.
29. Prass K, Meisel C, Hoflich C et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003 198 : 725 36.
30. Livingston DH, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC Jr. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988 123 : 1309 12.
31. Woiciechowsky C, Schoning B, Daberkow N et al. Brain-IL-1beta induces local inflammation but systemic anti-inflammatory response through stimulation of both hypothalamic-pituitary-adrenal axis and sympathetic nervous system. Brain Res 1999 816 : 563 71.
32. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003 34 : 2518 32.
33. Graves N, Nicholls TM, Wong CG, Morris AJ. The prevalence and estimates of the cumulative incidence of hospital-acquired infections among patients admitted to Auckland District Health Board Hospitals in New Zealand. Infect Control Hosp Epidemiol 2003 24 : 56 61.
34. Nguyen-Van-Tam SE, Nguyen-Van-Tam JS, Myint S, Pearson JC. Risk factors for hospital-acquired urinary tract infection in a large English teaching hospital: a case-control study. Infection 1999 27 : 192 7.
35. Hussain M, Oppenheim BA, O'Neill P, Trembath C, Morris J, Horan MA. Prospective survey of the incidence, risk factors and outcome of hospital-acquired infections in the elderly. J Hosp Infect 1996 32 : 117 26.
36. Poor nutritional status on admission predicts poor outcomes after stroke: observational data from the FOOD trial. Stroke 2003 34 : 1450 6.
37. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001 344 : 665 71.
38. Werner GT, Gadomski M, Scheinert B. The significance of urinary tract infections in patients with cerebrovascular diseases during clinical rehabilitation. Rehabilitation (Stuttg) 1998 37 : 64 7.
39. Kwan J, Hand P, Sandercock PA, Dennis MS. What are the consequences of urinary catheterisation in patients with acute stroke? Cerebrovasc Dis 2003 16 (Suppl. 4 26.
40. Johnson JR, Kuskowski MA, Wilt TJ. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med 2006 144 : 116 26.
41. Widdicombe J, Singh V. Physiological and pathophysiological down-regulation of cough. Respir Physiol Neurobiol 2006 150 : 105 17.
42. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003 60 : 620 5.
43. Hamidon BB, Raymond AA, Norlinah MI, Jefferelli SB. The predictors of early infection after an acute ischaemic stroke. Singapore Med J 2003 44 : 344 6.
44. Upadya A, Thorevska N, Sena KN, Manthous C, moateng-Adjepong Y. Predictors and consequences of pneumonia in critically ill patients with stroke. J Crit Care 2004 19 : 16 22.
45. Hilker R, Poetter C, Findeisen N et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 2003 34 : 975 81.
46. Kammersgaard LP, Jorgensen HS, Reith J et al. Early infection and prognosis after acute stroke: The Copenhagen Stroke Study. J Cereb Blood Flow Metab 2001 10 : 217 21.
47. Hack W, Kaste M, Bogousslavsky J et al. European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis 2003 16 : 311 37.
48. Meisel C, Prass K, Braun J et al. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 2004 35 : 2 6.
49. Shinohara Y. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage. Cerebrovasc Dis 2006 22 : 57 60.
50. Ohkubo T, Chapman N, Neal B, Woodward M, Omae T, Chalmers J. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med 2004 169 : 1041 5.
51. Sekizawa K, Matsui T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet 1998 352 : 1069.
52. Nakagawa T, Wada H, Sekizawa K, Arai H, Sasaki H. Amantadine and pneumonia. Lancet 1999 353 : 1157.